JULIET TAMMENOMS BAKKER

Juliet Tammenoms Bakker stands as a distinguished Managing Director at Longitude Capital, a leading healthcare venture capital firm renowned for its strategic investments in the life sciences sector. With a career spanning decades, Ms. Bakker has established herself as a pivotal figure in identifying and nurturing innovative companies poised to transform healthcare.

At Longitude Capital, Juliet Tammenoms Bakker plays a critical role in the firm's investment strategy, focusing on venture growth equity and later-stage opportunities. Her expertise primarily lies in the dynamic fields of biotechnology, medical devices, and pharmaceuticals. She is instrumental in evaluating companies developing novel drugs, cutting-edge medical technologies, and comprehensive health solutions, guiding them through various stages of growth and market entry. Her deep understanding of the scientific, clinical, and commercial aspects of the life sciences industry allows her to make informed decisions that drive significant value for both portfolio companies and investors.

Ms. Bakker's extensive career background is marked by significant leadership roles in top-tier financial institutions. Prior to joining Longitude Capital, she served as a Managing Director at Lehman Brothers, where she spearheaded the firm's healthcare venture capital business. In this capacity, she was responsible for overseeing a broad portfolio of healthcare investments, demonstrating her capability to manage complex financial strategies within the sector. Before her tenure at Lehman Brothers, Juliet was a Partner at the Sprout Group, the venture capital arm of DLJ (Donaldson, Lufkin & Jenrette). At Sprout, she honed her focus on healthcare investments, contributing to the growth and success of numerous early-stage and developing companies.

Her journey in finance began in healthcare investment banking at DLJ, providing her with a foundational understanding of corporate finance and strategic advisory within the healthcare industry. This comprehensive background, from investment banking to venture capital leadership, has equipped her with a unique perspective on the entire lifecycle of healthcare companies, from inception to market leadership. Ms. Bakker holds an MBA from Stanford Graduate School of Business and a BA from Yale University, underscoring her strong academic foundation.

While specific individual notable investments are often proprietary, Juliet Tammenoms Bakker's influence is evident in Longitude Capital's robust portfolio of successful life science companies. Her investment philosophy centers on backing companies with strong scientific foundations, clear clinical pathways, and significant market potential. Her strategic insights and hands-on approach have been crucial in helping many companies navigate the complex landscape of drug development and medical technology innovation, ultimately bringing vital new therapies and solutions to patients worldwide. Her contributions continue to shape the future of healthcare investment.